Policy crediting rate and indexed account parameter changes

At John Hancock, we are proud of our record of delivering exceptional policy performance for our customers. Our strong investment capabilities are at the core of this success. Continuing our focus in this area, we are making the following adjustments effective March 1, 2024:

Crediting rates will increase on the retail indexed UL Fixed Account — most products will increase by 30 basis points, while Accumulation IUL 23 and Premier Benefit IUL will increase by 80 basis points
For Accumulation IUL 23, participation rates will increase by 15%-20% on Barclays Global MA Indexed Accounts
Most caps for indexed accounts without an Indexed Performance Charge (IPC) will have an increase, while most caps for indexed accounts with an IPC or two-year durations will decrease
Crediting rates will increase by 5-10 basis points on certain retail UL products and VUL Fixed Accounts
Protection UL and Protection SUL crediting rates remain unchanged

Refer to the following materials for more details on these upcoming changes and our UL crediting-rate history. And reach out to your John Hancock sales representative or contact National Sales Support at 888-266-7498, option 2 if you have any questions.

See the changes

A historical view

Did you find this content helpful?

Yes

No

THIS MATERIAL IS FOR INSTITUTIONAL/BROKER-DEALER USE ONLY. NOT FOR DISTRIBUTION OR USE WITH THE PUBLIC.
Insurance policies and/or associated riders and features may not be available in all states.
Protection UL (PUL), Protection SUL (PSUL, Premier Benefit IUL (PBIUL), John Hancock variable life insurance policies and Barclays Global MA Indexed Accounts are not available in New York.
Index Account options may not be available on all products or in all jurisdictions. Please consult each product’s producer guide for index account option availability.
There is risk as the performance of the underlying index may result in low segment interest credits that would require increase in premium payments in order to the keep the policy in force.
Neither Barclays Bank PLC ('BB PLC'') nor any of its affiliates (collectively 'Barclays') is the issuer or producer of the John Hancock Life Insurance Company (U.S.A.)’s (the “Company” or the “Issuer”) life insurance products (the “Products”) and Barclays has no responsibilities, obligations or duties to purchasers of the Products. The Barclays Global MA Index (the “Index”) together with any Barclays indices that are components of the Index, is a trademark owned by Barclays and, together with any component indices and index data, is licensed for use by the Company as the issuer or producer of the Products. Barclays’ only relationship with the Issuer in respect of the Index is the licensing of the Index, which is administered, compiled and published by BB PLC in its role as the index sponsor (the “Index Sponsor”) without regard to the Issuer or the Products or purchasers of the Products. Additionally, the Company as issuer or producer of the Products may for itself execute transaction(s) with Barclays in or relating to the Index in connection with the Products. Purchasers acquire the Products from the Company and purchasers neither acquire any interest in the Index nor enter into any relationship of any kind whatsoever with Barclays upon purchase of the Products. The Products are not sponsored, endorsed, sold or promoted by Barclays and Barclays makes no representation regarding the advisability of the Products or use of the Index or any data included therein. Barclays shall not be liable in any way to the Issuer, Product purchaser or to other third parties in respect of the use or accuracy of the Index or any data included therein.
Variable universal life insurance has annual fees and expenses associated with it in addition to life insurance related charges. Variable universal life insurance products are subject to market risk and are unsuitable as a short term savings vehicle. Cash values are not guaranteed and will fluctuate, and the policy may lose value.
Variable life insurance is sold by product and fund prospectus, which should be read carefully. They contain information on the investment objectives, risks, charges and expenses of the variable product and its underlying investment options. These factors should be considered carefully before investing.

Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595 and securities are offered through John Hancock Distributors LLC through other broker/dealers that have a selling agreement with John Hancock Distributors LLC, 197 Clarendon Street, Boston, MA 02116.
MLINY012624050-1